Hot Features
Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Hold... Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 16686 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 9465 | 9.768E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 11509 | 9.887E-5 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 32786 | 9.37E-5 | CS |
| 156 | -0.0189 | -99.4736842105 | 0.019 | 0.02 | 1.0E-6 | 76803 | 0.00516084 | CS |
| 260 | -0.0998 | -99.8998998999 | 0.0999 | 0.12 | 1.0E-6 | 228724 | 0.02219568 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.